| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.008 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.009 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.009 |
| mRNA | phenformin | GDSC1000 | pan-cancer | AAC | 0.078 | 0.009 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.078 | 0.01 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |